α-半乳糖苷酶A基因Ala143Thr变异相关心肌病
本研究对一个携带GLA基因A143T变异的心肌病女性先证者及其10名亲属进行筛查,发现A143T/GLA可能为迟发型法布雷心肌病致病性变异,外显率不全。携带者出现窦房结功能不全、房室传导阻滞、左室肥厚/扩张及钆延迟强化等表现,部分女性亲属无心肌病表现。
要点
- A143T/GLA可能为迟发型法布雷心肌病致病性变异,外显率不全。
- 携带者可出现窦房结功能不全、房室传导阻滞及左室肥厚/扩张。
- 心脏磁共振T1时间及FDG PET/CT有助于评估心肌受累。
核心结论
- A143T/GLA可能为迟发型法布雷心肌病致病性变异,外显率不全。
研究设计与样本
- 对一名60余岁心肌病女性先证者筛查59个心肌病相关基因,发现A143T/GLA为唯一罕见变异,并在10名亲属中筛查该变异。
主要发现
- 先证者及其长子因窦房结功能不全和房室传导阻滞植入起搏器。
- 两名儿子和一名孙女GLA活性降至正常的25%-40%,两名儿子Lyso-Gb3水平升高。
- 心脏磁共振显示先证者及两名儿子有左室肥厚和/或扩张;长子基底下侧壁钆延迟强化、T1时间升高且FDG PET/CT阳性,次子T1时间降低,母亲FDG PET/CT基底下侧壁阳性。
- 两名儿子心内膜心肌活检光镜和电镜显示符合糖脂质累积,次子抗Gb3抗体染色可用。
- 5名携带A143T/GLA的女性亲属心脏影像未见心肌病。
临床怎么用
- 对携带A143T/GLA者应评估法布雷心肌病,包括GLA活性、Lyso-Gb3、心脏影像及必要时活检。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether the Ala143Thr variant of the α-galactosidase A gene (A143T/GLA), with conflicting interpretations of pathogenicity, is associated with Fabry cardiomyopathy. METHODS: The index patient, a woman in her 60s with cardiomyopathy, was screened for variants in 59 cardiomyopathy-related genes. A143T/GLA, the only rare variant found, was screened in 10 relatives. GLA activity and lyso-Gb3 levels were measured and echocardiography was performed in 8 of 9 subjects carrying A143T/GLA. Cardiac magnetic resonance (CMR) imaging and 18F-fluorodeoxyglucose (FDG) positron emission tomography/CT (PET/CT) were performed in four adult A143T/GLA carriers. Endomyocardial biopsy was obtained from two adult A143T/GLA carrying sons of the index patient. RESULTS: The index patient and her elder son had a pacemaker implantation because of sick sinus syndrome and atrioventricular block. GLA activities were decreased to 25%-40% of normal in both sons and one granddaughter. Lyso-Gb3 levels were elevated in both sons. In CMR, the index patient and her two sons had left ventricular (LV) hypertrophy and/or dilatation. The elder son had late gadolinium enhancement, high CMR-derived T1 time and positive FDG signal in PET/CT in the basal inferolateral LV wall. The younger son had low T1 time and the mother had positive FDG signal in PET/CT in the basal inferolateral LV wall. Endomyocardial biopsy of both sons showed myocardial accumulation compatible with glycolipids in light and electron microscopy, staining with anti-Gb3 antibody available for the younger son. Five female relatives with A143T/GLA had no cardiomyopathy in cardiac imaging. CONCLUSIONS: A143T/GLA is likely a late-onset Fabry cardiomyopathy causing variant with incomplete penetrance.
引用
- Valtola K, Nino-Quintero J, Hedman M, et al. Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene. Heart. 2020. PMID: 31949022. doi:10.1136/heartjnl-2019-315933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。